Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation.
CONCLUSION: The promising effects of patented agents against IL-17A may open new opportunities to therapeutic intervention targeting at different levels of involvement in the pathogenesis of cancer and inflammatory diseases.
PMID: 29468982 [PubMed - as supplied by publisher]
Source: Recent Patents on Anti-Cancer Drug Discovery - Category: Cancer & Oncology Tags: Recent Pat Anticancer Drug Discov Source Type: research
More News: Arthritis | Autoimmune Disease | Cancer | Cancer & Oncology | Multiple Sclerosis | Psoriasis | Rheumatoid Arthritis | Rheumatology